Terms: = Prostate cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
10 results:
1. hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/hmga2 axis.
Wang P; Zhang L; Yin S; Xu Y; Tai S; Zhang LI; Liang C
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):815-822. PubMed ID: 33978716
[TBL] [Abstract] [Full Text] [Related]
2. cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
Qin C; Sheng Z; Huang X; Tang J; Liu Y; Xu T; Qiu X
Prostate; 2020 Sep; 80(13):1134-1144. PubMed ID: 32628304
[TBL] [Abstract] [Full Text] [Related]
3. Programing Assembling/Releasing Multifunctional miRNA Nanomedicine to Treat prostate cancer.
Ma D; Liu H; Zhao P; Ye L; Zou H; Zhao X; Dai H; Kong X; Liu P
ACS Appl Mater Interfaces; 2020 Feb; 12(8):9032-9040. PubMed ID: 31986004
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through hmga2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract] [Full Text] [Related]
5. High mobility group A2 (hmga2) promotes EMT via MAPK pathway in prostate cancer.
Hawsawi O; Henderson V; Burton LJ; Dougan J; Nagappan P; Odero-Marah V
Biochem Biophys Res Commun; 2018 Sep; 504(1):196-202. PubMed ID: 30177390
[TBL] [Abstract] [Full Text] [Related]
6. A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy.
Wang L; Qu M; Huang S; Fu Y; Yang L; He S; Li L; Zhang Z; Lin Q; Zhang L
Nanoscale; 2018 Jul; 10(28):13673-13683. PubMed ID: 29987301
[TBL] [Abstract] [Full Text] [Related]
7. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of hmga2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract] [Full Text] [Related]
9. New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
Marra M; Salzano G; Leonetti C; Porru M; Franco R; Zappavigna S; Liguori G; Botti G; Chieffi P; Lamberti M; Vitale G; Abbruzzese A; La Rotonda MI; De Rosa G; Caraglia M
Biotechnol Adv; 2012; 30(1):302-9. PubMed ID: 21741464
[TBL] [Abstract] [Full Text] [Related]
10. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
[TBL] [Abstract] [Full Text] [Related]